Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

VRCA Verrica Pharmaceuticals Inc. Common Stock
$6.32 -1.02% -0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy VRCA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 108.6M
Enterprise value 80.1M
Forward PE -3.706745
PEG Ratio -3.706745
Enterprise to EBITDA -6.989
Enterprise to revenue 2.25
Price to book MRQ 4.388889
Price to sales TTM 3.0516887

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 35.6M
EBITDA -11454000
Diluted EPS TTM -1.68
Total Cash (MRQ) 30.1M
Current ratio (MRQ) 2.588
Operating Cash Flow (TTM) -17627000

VRCA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent VRCA News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.